DrugDashboards

Mucus Relief DM

Guaifenesin Dextromethorphan HBr · DEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1 · Tablet, Extended Release · Oral · QUALITY CHOICE (Chain Drug Marketing Association)

NDC 83324-0137-14 · 14 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.5459 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Jan 2025Sep 2026$0.5459
20 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$16.38
#90 count
$49.13

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for guaifenesin and dextromethorphan hbr (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA209692
TE code
Approval date
Nov 1, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Guaifenesin Dextromethorphan HBr (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
QUALITY CHOICE (Chain Drug Marketing Association)DEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Mucus Relief DM — NDC 83324-0137-14," retrieved September 3, 2026, https://drugdashboards.com/drug/83324013714.

Free to cite with attribution — see how the data is put together.